Literature DB >> 29377177

EAACI Position paper on the standardization of nasal allergen challenges.

J Augé1,2, J Vent1,2,3, I Agache4, L Airaksinen5, P Campo Mozo6, A Chaker7, C Cingi8, S Durham9, W Fokkens10, P Gevaert11, A Giotakis12, P Hellings13, M Herknerova14, V Hox13, L Klimek15, C La Melia16, J Mullol17,18,19, N B Muluk20, A Muraro21, K Naito22, O Pfaar15,3, H Riechelmann12, C Rondon6, M Rudenko23, B Samolinski24, I Tasca16, P Tomazic25, K Vogt26, M Wagenmann27, G Yeryomenko28, L Zhang29, R Mösges2.   

Abstract

Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhinitis. In daily clinical routine, experimentally, or when measuring therapeutic success clinically, nasal allergen challenge is fundamental. It is further one of the key diagnostic tools when initiating specific allergen immunotherapy. So far, national recommendations offered guidance on its execution; however, international divergence left many questions unanswered. These differences in the literature caused EAACI to initiate a task force to answer unmet needs and find a consensus in executing nasal allergen challenge. On the basis of a systematic review containing nasal allergen challenges of the past years, task force members reviewed evidence, discussed open issues, and studied variations of several subjective and objective assessment parameters to propose a standardized way of a nasal allergen challenge procedure in clinical practice. Besides an update on indications, contraindications, and preparations for the test procedure, main recommendations are a bilaterally challenge with standardized allergens, with a spray device offering 0.1 mL per nostril. A systematic catalogue for positivity criteria is given for the variety of established subjective and objective assessment methods as well as a schedule for the challenge procedure. The task force recommends a unified protocol for NAC for daily clinical practice, aiming at eliminating the previous difficulty of comparing NAC results due to unmet needs.
© 2018 EAACI and John Wiley and Sons A/S. Published by John Wiley and Sons Ltd.

Entities:  

Keywords:  allergic rhinitis; diagnostic tools; nasal allergen challenge; nasal provocation test

Mesh:

Substances:

Year:  2018        PMID: 29377177     DOI: 10.1111/all.13416

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  30 in total

1.  IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper.

Authors:  Ignacio J Ansotegui; Giovanni Melioli; Giorgio Walter Canonica; Luis Caraballo; Elisa Villa; Motohiro Ebisawa; Giovanni Passalacqua; Eleonora Savi; Didier Ebo; R Maximiliano Gómez; Olga Luengo Sánchez; John J Oppenheimer; Erika Jensen-Jarolim; David A Fischer; Tari Haahtela; Martti Antila; Jean J Bousquet; Victoria Cardona; Wen Chin Chiang; Pascal M Demoly; Lawrence M DuBuske; Marta Ferrer Puga; Roy Gerth van Wijk; Sandra Nora González Díaz; Alexei Gonzalez-Estrada; Edgardo Jares; Ayse Füsun Kalpaklioğlu; Luciana Kase Tanno; Marek L Kowalski; Dennis K Ledford; Olga Patricia Monge Ortega; Mário Morais Almeida; Oliver Pfaar; Lars K Poulsen; Ruby Pawankar; Harald E Renz; Antonino G Romano; Nelson A Rosário Filho; Lanny Rosenwasser; Mario A Sánchez Borges; Enrico Scala; Gian-Enrico Senna; Juan Carlos Sisul; Mimi L K Tang; Bernard Yu-Hor Thong; Rudolf Valenta; Robert A Wood; Torsten Zuberbier
Journal:  World Allergy Organ J       Date:  2020-02-25       Impact factor: 4.084

2.  Responders and nonresponders to pharmacotherapy and allergen immunotherapy.

Authors:  Marek Jakalski; Andrzej Bozek; G Walter Canonica
Journal:  Hum Vaccin Immunother       Date:  2019-06-21       Impact factor: 3.452

3.  Nasal mucosal reactivity assessment via a double-blind placebo-controlled food challenge with cow's milk allergens.

Authors:  Edyta Krzych-Fałta; Oksana Wojas; Piotr Samel-Kowalik; Adam J Sybilski; Bolesław Samoliński
Journal:  Allergy Asthma Clin Immunol       Date:  2022-07-01       Impact factor: 3.373

4.  Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma.

Authors:  Jef Feijen; Sven F Seys; Brecht Steelant; Dominique M A Bullens; Lieven J Dupont; Maria García-Cruz; Alejandro Jimenez-Chobillón; Désirée Larenas-Linnemann; Laura Van Gerven; Wytske J Fokkens; Ioana Agache; Peter W Hellings
Journal:  World Allergy Organ J       Date:  2020-07-01       Impact factor: 4.084

5.  Nasal IgE in subjects with allergic and non-allergic rhinitis.

Authors:  Jonas Eckrich; Julia Hinkel; Anna Fischl; Eva Herrmann; Gabriele Holtappels; Claus Bachert; Stefan Zielen
Journal:  World Allergy Organ J       Date:  2020-06-23       Impact factor: 4.084

Review 6.  Clinical trials in allergen immunotherapy: current concepts and future needs.

Authors:  O Pfaar; M Alvaro; V Cardona; E Hamelmann; R Mösges; J Kleine-Tebbe
Journal:  Allergy       Date:  2018-04-16       Impact factor: 13.146

7.  Precision medicine allergy immunoassay methods for assessing immunoglobulin E sensitization to aeroallergen molecules.

Authors:  Florin-Dan Popescu; Mariana Vieru
Journal:  World J Methodol       Date:  2018-11-29

Review 8.  Local Respiratory Allergy: From Rhinitis Phenotype to Disease Spectrum.

Authors:  Almudena Testera-Montes; Maria Salas; Francisca Palomares; Adriana Ariza; María J Torres; Carmen Rondón; Ibon Eguiluz-Gracia
Journal:  Front Immunol       Date:  2021-06-02       Impact factor: 7.561

9.  Subcutaneous immunotherapy induces alterations in monocytes and dendritic cells homeostasis in allergic rhinitis patients.

Authors:  Letícia Sousa; Carmen Martín-Sierra; Celso Pereira; Graça Loureiro; Beatriz Tavares; Susana Pedreiro; António Martinho; Artur Paiva
Journal:  Allergy Asthma Clin Immunol       Date:  2018-11-15       Impact factor: 3.406

10.  Occupational allergic rhinoconjunctivitis to Tachypleus amoebocyte lysate: a case report.

Authors:  Ying-Yang Xu; Jun-Da Li; Kai Guan
Journal:  Chin Med J (Engl)       Date:  2020-03-20       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.